Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma

British Journal of Surgery

Volumn 95, Issue 7, 2008, Pages 827-833

  Ni Mhuircheartaigh J ^a   Curran, C ^a   Hennessy, E ^a   Kerin, M J ^a,b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; CONFERENCE PAPER; DATA BASE; HUMAN; INTERNATIONAL UNION AGAINST CANCER STAGE; INVASIVE DUCTAL BREAST CARCINOMA; INVASIVE LOBULAR BREAST CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; ARTICLE; BREAST TUMOR; FEMALE; LUNG CARCINOMA; MORTALITY; PAGET NIPPLE DISEASE; SURVIVAL; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 47249096525     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6042     Document Type: Conference Paper

References (22)

1. Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 2005; 242: 281-289.
2. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 1227-1232.
3. Smith IE, Ross GM. Breast radiotherapy after lumpectomy - no longer always necessary. N Engl J Med 2004; 351: 1021-1023.
4. Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 2000; 88: 2561-2569.
5. Verkooijen HM, Fioretta G, Vlastos G, Morabia A, Schubert H, Sappino AP et al. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 2001; 104: 778-781.
6. Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 1998; 186: 416-422.
7. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996; 77: 113-120.
8. Ladekarl M, Sorensen FB. Prognostic, quantitative histopathologic variables in lobular carcinoma of the breast. Cancer 1993; 72: 2602-2611.
9. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004; 6: R149-R156.
10. Cornford EJ, Wilson AR, Athanassiou E, Galea M, Ellis IO, Elston CW, et al. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol 1995; 68: 450-453.
11. Butler RS, Venta LA, Wiley EL, Ellis RL, Dempsey PJ, Rubin E. Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol 1999; 172: 325-330.
12. Le Gal M, Ollivier L, Asselain B, Meunier M, Laurent M, Vielh P et al. Mammographic features of 455 invasive lobular carcinomas. Radiology 1992; 185: 705-708.
13. Rissanen T, Tikkakoski T, Autio AL, Apaja-Sarkkinen M. Ultrasonography of invasive lobular breast carcinoma. Acta Radiol 1998; 39: 285-291.
14. Paramagul CP, Helvie MA, Adler DD. Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology 1995; 195: 231-234.
15. Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 2003; 163: 2149-2153.
16. Sinha PS, Bendall S, Bates T. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers? Eur J Surg Oncol 2000; 26: 733-737.
17. Smith DB, Howell A, Wagstaff J. Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival. Eur J Cancer Clin Oncol 1987; 23: 979-982.
18. Mersin H, Yildirim E, Gulben K, Berberoglu U. Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 2003; 29: 390-395.
19. Haybittle JL, Blarney RW, Elston CW, Johnson J, Doyle PJ, Campbell FC et al. A prognostic index in primary breast cancer. Br J Cancer 1982; 45: 361-366.
20. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 2001; 21: 1973-1979.
21. Shaaban AM, Speirs V. The estrogen receptors alpha, beta, and beta cx. Clin Cancer Res 2005; 11: 8222; author reply 8222-8223.
22. Speirs V, Kerin MJ. Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 2000; 87: 405-409.